Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2023	12-2022	12-2021	12-2020	12-2019
Assets
Current Assets
Cash & Cash Equivalents	137,879	108,965	110,623	333,558	171,160
Marketable Securities	116,586	231,742	114,448	102,947	118,955
Receivables	27,676	11,339	3,348	1,829	N/A
Inventories	45,579	18,325	10,154	5,876	0
TOTAL	$338,865	$374,727	$246,117	$450,003	$296,602

Non-Current Assets
PPE Net	17,225	13,799	24,661	17,499	14,755
Intangibles	9,808	112,519	202,298	218,307	0
Other Non-Current Assets	112,556	80,855	58,087	34,411	28,930
TOTAL	$139,589	$207,173	$285,046	$270,217	$43,685

Total Assets	$478,454	$581,900	$531,163	$720,220	$340,287

Liabilities
Current Liabilities
Short Term Debt	2,500	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	13,809	4,546	10,603	12,657	8,010
Accrued Expenses	53,824	59,357	39,558	32,938	18,636
Other current liabilities	N/A	N/A	3,020	3,081	2,952
TOTAL	$89,224	$75,682	$67,289	$60,964	$40,979

Non-Current Liabilities
Deferred Revenues	10,737	6,867	9,362	7,851	7,911
Other Non-Current Liabilities	470,415	415,041	321,251	207,672	25,870
TOTAL	$540,834	$493,618	$395,403	$284,966	$73,818

Total Liabilities	$630,058	$569,300	$462,692	$345,930	$114,797

Shareholders' Equity
Shares Outstanding, K	88,214	82,800	71,453	71,378	56,927
Common Shares	88	82	72	69	52
Retained earnings	-2,078,360	-1,754,374	-1,397,952	-1,126,293	-844,204
Other shareholders' equity	14	-374	-18	0	3
TOTAL	$-151,604	$12,600	$68,471	$374,290	$225,490

Total Liabilities And Equity	$478,454	$581,900	$531,163	$720,220	$340,287